News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MAYLEBEN TIMOTHY M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/24/2023 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on Landos Biopharma, Inc.|
Txns:
| Granted 18,000 options to buy
@ $0.33, valued at
$5.9k
|
|
| 01/30/2023 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS, INC.|
Txns:
| Granted 3,600 shares
@ $0
Granted 16,200 options to buy
@ $5.94, valued at
$96.2k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 2,750 shares
@ $0
Granted 12,375 options to buy
@ $10.4, valued at
$128.7k
|
|
| 12/21/2021 |
4
| MAYLEBEN TIMOTHY M (Interim CEO) has filed a Form 4 on Landos Biopharma, Inc.|
Txns:
| Granted 253,485 options to buy
@ $4.95, valued at
$1.3M
|
|
| 05/17/2021 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on Landos Biopharma, Inc.|
Txns:
| Granted 36,000 options to buy
@ $10.2, valued at
$367.2k
|
|
| 01/29/2021 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 175,000 options to buy
@ $32.12, valued at
$5.6M
|
|
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $2.07, valued at
$207k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2019 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $36.98, valued at
$184.9k
|
|
| 09/06/2019 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 4,852 shares
@ $34.22, valued at
$166k
Bought 148 shares
@ $33.42, valued at
$4.9k
Bought 2,500 shares
@ $35.25, valued at
$88.1k
|
|
| 08/02/2019 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $39.56, valued at
$197.8k
|
|
| 07/01/2019 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $46, valued at
$230k
|
|
| 04/01/2019 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $40, valued at
$200k
|
|
| 03/21/2019 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $43.48, valued at
$217.4k
|
|
| 03/14/2019 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Bought 5,000 shares
@ $48.73, valued at
$243.7k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2018 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $52.38, valued at
$5.8M
|
|
| 06/14/2018 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 8,750 options to buy
@ $180.98, valued at
$1.6M
|
|
| 06/11/2018 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 10,000 shares
@ $179.5469, valued at
$1.8M
Exercised 7,416 options to buy
@ $20.91, valued at
$155.1k
Exercised 2,584 options to buy
@ $24.18, valued at
$62.5k
|
|
| 02/01/2018 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc.|
Txns:
| Exercised 1,939 options to buy
@ $1.05, valued at
$2k
Exercised 2,610 options to buy
@ $1.26, valued at
$3.3k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2017 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 10,000 shares
@ $80.4948, valued at
$804.9k
|
|
| 12/08/2017 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC|
Txns:
| Granted 35,000 options to buy
@ $6.19, valued at
$216.7k
|
|
| 11/27/2017 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 3,000 shares
@ $75.8542, valued at
$227.6k
Exercised 3,000 options to buy
@ $20.91, valued at
$62.7k
|
|
| 06/23/2017 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 11,000 options to buy
@ $78.58, valued at
$864.4k
|
|
| 02/22/2017 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc. |
| 01/19/2017 |
4
| MAYLEBEN TIMOTHY M (Director) has filed a Form 4 on MARINUS PHARMACEUTICALS INC |
| 01/03/2017 |
4
| MAYLEBEN TIMOTHY M (President & CEO) has filed a Form 4 on Esperion Therapeutics, Inc. |
|
|
|